Mirae Asset Healthcare Fund Direct Growth

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 43.966 ↓ -0.11%
[as on 6 March, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Mirae Asset Healthcare Fund Direct Growth and its peers as on 6 March, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Mirae Asset Healthcare Fund Direct Growth 2.84% -0.11% -0.38% 6.49% 1.68% 14.21% 26.81% 17.76% 22.65%-
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -6.88% -0.48% -2.33% -2.98% -7.15% 0.58% 13.01% 15.94% 15.17% 15.96%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -5.68% -1.18% -3.5% -3.99% -6.28% 8.33% 13.66% 11.75% 13.69% 13.62%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 2.01% -0.09% -0.62% 4.31% 0.05% 8.52% 27.17% 18.41% 21.54% 13.29%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -4.22% -0.61% -3.2% -3.17% -3.24% 8.99% 20.54% 19.96% 19.54% 17.48%
SBI PSU Fund - DIRECT PLAN - GROWTH 6.09% -0.46% -2.93% 1.91% 8.44% 29.55% 33.66% 28.09% 21.61% 17.17%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns---8.32%77.37%27.95%-10.87%36.86%41.36%-2.65%

Discrete returns (monthly)

MonthMay 2025Jun 2025Jul 2025Aug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026
Returns0.24%3.49%4.44%-1.25%-0.93%1.89%-0.38%-0.71%-5.19%7.4%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns13.77%1.36%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.31% 0.01% (Arbitrage: 0.00%) 0.00% 0.00% 0.68%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology12.01%
Divi's Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.88%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.41%
Apollo Hospitals Enterprise Ltd.APOLLOHOSP (INE437A01024)Healthcare Services6.21%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals & Biotechnology5.42%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology5.07%
Fortis Healthcare Ltd.FORTIS (INE061F01013)Healthcare Services4.33%
Aurobindo Pharma Ltd.AUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology4.09%
Dr. Reddy's Laboratories Ltd.DRREDDY (INE089A01031)Pharmaceuticals & Biotechnology4.02%
Krishna Institute of Medical Sciences Ltd.KIMS (INE967H01025)Healthcare Services3.77%
IPCA Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology3.56%
Aster DM Healthcare Ltd.ASTERDM (INE914M01019)Healthcare Services3.48%
Eris Lifesciences Ltd.ERIS (INE406M01024)Pharmaceuticals & Biotechnology3.20%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology3.19%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology2.81%
Cohance Lifesciences Ltd.COHANCE (INE03QK01018)Pharmaceuticals & Biotechnology2.77%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology2.72%
Onesource Specialty Pharma Ltd.ONESOURCE (INE013P01021)Pharmaceuticals & Biotechnology2.70%
JB Chemicals & Pharmaceuticals Ltd.JBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology2.68%
Sai Life Sciences Ltd.SAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.56%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.61%
Mankind Pharma Ltd.MANKIND (INE634S01028)Pharmaceuticals & Biotechnology1.55%
Anthem Biosciences Ltd.ANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology1.32%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.28%
Rubicon Research Ltd.RUBICON (INE506V01022)Pharmaceuticals & Biotechnology0.82%
Deepak Nitrite Ltd.DEEPAKNTR (INE288B01029)Chemicals & Petrochemicals0.76%
Sagility Ltd.SAGILITY (INE0W2G01015)IT - Services0.59%
Neogen Chemicals Ltd.NEOGEN (INE136S01016)Chemicals & Petrochemicals0.53%
Syngene International Ltd.SYNGENE (INE398R01022)Healthcare Services0.52%
Laxmi Dental Ltd.LAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.45%
Biocon Ltd.BIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.01%

Debt

NameRatingWeight %
Mirae Asset Liquid Fund-Direct Plan-Growth0.01%
Portfolio data is as on date 31 October, 2025

NAV history

Mirae Asset Healthcare Fund Direct Growth - 30 days NAV (Net asset value) history

DateNAV
6 March, 202643.966
5 March, 202644.014
4 March, 202643.326
2 March, 202643.939
27 February, 202644.133
26 February, 202644.485
25 February, 202643.965
24 February, 202643.393
23 February, 202643.253
20 February, 202642.896
19 February, 202642.904
18 February, 202643.074
17 February, 202642.965
16 February, 202642.719
13 February, 202642.330
12 February, 202642.840
11 February, 202642.800
10 February, 202642.109
9 February, 202642.122
6 February, 202641.285
5 February, 202641.426
4 February, 202641.409
3 February, 202641.648
2 February, 202640.533
30 January, 202640.911
29 January, 202640.460
28 January, 202640.757
27 January, 202640.691
23 January, 202640.736
22 January, 202641.302

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Mirae Asset Healthcare Fund Direct Growth?
    The latest NAV of Mirae Asset Healthcare Fund Direct Growth is 43.966 as on 6 March, 2026.
  • What are YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth?
    The YTD (year to date) returns of Mirae Asset Healthcare Fund Direct Growth are 2.84% as on 6 March, 2026.
  • What are 1 year returns of Mirae Asset Healthcare Fund Direct Growth?
    The 1 year returns of Mirae Asset Healthcare Fund Direct Growth are 14.21% as on 6 March, 2026.
  • What are 3 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
    The 3 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 26.81% as on 6 March, 2026.
  • What are 5 year CAGR returns of Mirae Asset Healthcare Fund Direct Growth?
    The 5 year annualized returns (CAGR) of Mirae Asset Healthcare Fund Direct Growth are 17.76% as on 6 March, 2026.